Daohai Du

639 total citations
21 papers, 446 citations indexed

About

Daohai Du is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Daohai Du has authored 21 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Immunology. Recurrent topics in Daohai Du's work include Epigenetics and DNA Methylation (6 papers), Cancer-related gene regulation (5 papers) and Protein Degradation and Inhibitors (4 papers). Daohai Du is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Cancer-related gene regulation (5 papers) and Protein Degradation and Inhibitors (4 papers). Daohai Du collaborates with scholars based in China, France and United States. Daohai Du's co-authors include Cheng Luo, Fei Ye, Shiyun Lv, Tongtong Zhang, Fei Guo, Liping Zhou, Shujia Zhu, Lin He, Youyi Zhang and Hong Ding and has published in prestigious journals such as Nature, Nucleic Acids Research and Biochemical Journal.

In The Last Decade

Daohai Du

20 papers receiving 436 citations

Peers

Daohai Du
Crystal C. Walline United States
Sixue Zhang United States
Jessica S. Fortin United States
Alexandra J. Gadiano United States
Nisha K. Ramakrishnan Netherlands
Joyce Ka Yu Tse Hong Kong
Xuejian Feng China
Obiamaka Obianyo United States
Zhijian Hu United States
Crystal C. Walline United States
Daohai Du
Citations per year, relative to Daohai Du Daohai Du (= 1×) peers Crystal C. Walline

Countries citing papers authored by Daohai Du

Since Specialization
Citations

This map shows the geographic impact of Daohai Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daohai Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daohai Du more than expected).

Fields of papers citing papers by Daohai Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daohai Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daohai Du. The network helps show where Daohai Du may publish in the future.

Co-authorship network of co-authors of Daohai Du

This figure shows the co-authorship network connecting the top 25 collaborators of Daohai Du. A scholar is included among the top collaborators of Daohai Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daohai Du. Daohai Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Qing, Jingqiu Liu, Zhou Chen, et al.. (2025). Discovery of aldolase A inhibitors via high-throughput screening assay based on an enzymatic coupling reaction. Bioorganic & Medicinal Chemistry Letters. 128. 130332–130332.
2.
Fan, Shijie, Xueyuan Li, Daohai Du, et al.. (2024). Structure-Based Design and Discovery of a Potent and Cell-Active LC3A/B Covalent Inhibitor. Journal of Medicinal Chemistry. 67(14). 12184–12204. 3 indexed citations
3.
Du, Daohai, Hongwen Zhu, Xiongjun Wang, et al.. (2024). Uncovering PROTAC Sensitivity and Efficacy by Multidimensional Proteome Profiling: A Case for STAT3. Journal of Medicinal Chemistry. 67(6). 4804–4818. 7 indexed citations
4.
Jiang, Hao, Qiao Guo, Huimin Zhang, et al.. (2023). A RhoA structure with switch II flipped outward revealed the conformational dynamics of switch II region. Journal of Structural Biology. 215(2). 107942–107942. 3 indexed citations
5.
Ni, Yicheng, et al.. (2023). Thimerosal, a competitive thioredoxin reductase 1 (TrxR1) inhibitor discovered via high-throughput screening. Biochemical and Biophysical Research Communications. 650. 117–122. 4 indexed citations
6.
Wu, Qiqi, Zhifeng Chen, Jingqiu Liu, et al.. (2022). The discovery of a non-competitive GOT1 inhibitor, hydralazine hydrochloride, via a coupling reaction-based high-throughput screening assay. Bioorganic & Medicinal Chemistry Letters. 73. 128883–128883. 5 indexed citations
7.
Liu, Liping, Rui Zhu, Jiacheng Li, et al.. (2022). Computational and Structure-Based Development of High Potent Cell-Active Covalent Inhibitor Targeting the Peptidyl-Prolyl Isomerase NIMA-Interacting-1 (Pin1). Journal of Medicinal Chemistry. 65(3). 2174–2190. 15 indexed citations
8.
Du, Daohai, Y. Liu, Tian Lu, et al.. (2021). Discovery and characterization of a novel glucose-6-phosphate dehydrogenase (G6PD) inhibitor via high-throughput screening. Bioorganic & Medicinal Chemistry Letters. 40. 127905–127905. 9 indexed citations
9.
Zhang, Youyi, Fei Ye, Tongtong Zhang, et al.. (2021). Structural basis of ketamine action on human NMDA receptors. Nature. 596(7871). 301–305. 130 indexed citations
10.
Zhou, Yan, Daohai Du, Jia Wang, et al.. (2020). Identification of catalytic and non‐catalytic activity inhibitors against PRC2‐EZH2 complex through multiple high‐throughput screening campaigns. Chemical Biology & Drug Design. 96(4). 1024–1051. 7 indexed citations
11.
Liao, Liping, Yu Zuo, Dan Zhang, et al.. (2019). Discovery of novel CBP bromodomain inhibitors through TR-FRET-based high-throughput screening. Acta Pharmacologica Sinica. 41(2). 286–292. 13 indexed citations
12.
13.
14.
Zhang, Rukang, Jiang Wang, Liang Zhao, et al.. (2018). Identification of novel inhibitors of histone acetyltransferase hMOF through high throughput screening. European Journal of Medicinal Chemistry. 157. 867–876. 14 indexed citations
15.
Du, Daohai, Junchi Hu, Lianchun Li, et al.. (2017). Development of a high-throughput fluorescence polarization assay for the discovery of EZH2-EED interaction inhibitors. Acta Pharmacologica Sinica. 39(2). 302–310. 25 indexed citations
16.
Hu, Junchi, Hong Ding, Limin Chen, et al.. (2016). Identification of novel EZH2 inhibitors through pharmacophore-based virtual screening and biological assays. Bioorganic & Medicinal Chemistry Letters. 26(15). 3813–3817. 17 indexed citations
17.
Kong, Xiangqian, Limin Chen, Lianying Jiao, et al.. (2014). Astemizole Arrests the Proliferation of Cancer Cells by Disrupting the EZH2-EED Interaction of Polycomb Repressive Complex 2. Journal of Medicinal Chemistry. 57(22). 9512–9521. 86 indexed citations
18.
19.
Zhou, Xiao-Long, et al.. (2011). Role of tRNA amino acid-accepting end in aminoacylation and its quality control. Nucleic Acids Research. 39(20). 8857–8868. 37 indexed citations
20.
Liu, Ru‐Juan, Min Tan, Daohai Du, et al.. (2011). Peripheral insertion modulates the editing activity of the isolated CP1 domain of leucyl-tRNA synthetase. Biochemical Journal. 440(2). 217–227. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Crystal C. Walline Breakdown of academic impact, for papers by Sixue Zhang Breakdown of academic impact, for papers by Jessica S. Fortin Breakdown of academic impact, for papers by Alexandra J. Gadiano Breakdown of academic impact, for papers by Nisha K. Ramakrishnan Breakdown of academic impact, for papers by Joyce Ka Yu Tse Breakdown of academic impact, for papers by Xuejian Feng Breakdown of academic impact, for papers by Obiamaka Obianyo Breakdown of academic impact, for papers by Zhijian Hu
Rankless by CCL
2026